BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 38750677)

  • 1. Pro-inflammatory cytokines and CXC chemokines as game-changer in age-associated prostate cancer and ovarian cancer: Insights from preclinical and clinical studies' outcomes.
    Ullah A; Chen Y; Singla RK; Cao D; Shen B
    Pharmacol Res; 2024 Jun; 204():107213. PubMed ID: 38750677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of proinflammatory cytokines and CXC chemokines (CXCL1-CXCL16) in the progression of prostate cancer: insights on their therapeutic management.
    Ullah A; Jiao W; Shen B
    Cell Mol Biol Lett; 2024 May; 29(1):73. PubMed ID: 38745115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate tumor CXC-chemokine profile correlates with cell adhesion to endothelium and extracellular matrix.
    Engl T; Relja B; Blumenberg C; Müller I; Ringel EM; Beecken WD; Jonas D; Blaheta RA
    Life Sci; 2006 Mar; 78(16):1784-93. PubMed ID: 16263140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CCR1 chemokines promote the chemotactic recruitment, RANKL development, and motility of osteoclasts and are induced by inflammatory cytokines in osteoblasts.
    Yu X; Huang Y; Collin-Osdoby P; Osdoby P
    J Bone Miner Res; 2004 Dec; 19(12):2065-77. PubMed ID: 15537451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening of CXC chemokines in the microenvironment of ovarian cancer and the biological function of CXCL10.
    Li W; Ma JA; Sheng X; Xiao C
    World J Surg Oncol; 2021 Nov; 19(1):329. PubMed ID: 34794429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploration of prognostic biomarkers and therapeutic targets in the microenvironment of bladder cancer based on CXC chemokines.
    Sun X; Chen Q; Zhang L; Chen J; Zhang X
    Math Biosci Eng; 2021 Jul; 18(5):6262-6287. PubMed ID: 34517533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CXC chemokines and prostate cancer: growth regulators and potential biomarkers.
    Lentsch AB
    Future Oncol; 2006 Oct; 2(5):651-8. PubMed ID: 17026456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioinformatics Analysis of Potential Therapeutic Targets and Prognostic Biomarkers amid CXC Chemokines in Ovarian Carcinoma Microenvironment.
    Jin Y; Lin Q; Fei H; Xue L; Li L; Xi Q; Jiang H
    J Oncol; 2021; 2021():8859554. PubMed ID: 33763130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progressive dysregulation of transcription factors NF-kappa B and STAT1 in prostate cancer cells causes proangiogenic production of CXC chemokines.
    Shen H; Lentsch AB
    Am J Physiol Cell Physiol; 2004 Apr; 286(4):C840-7. PubMed ID: 14656722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CXC chemokines influence immune surveillance in immunological disorders: Polycystic ovary syndrome and endometriosis.
    Ullah A; Wang MJ; Wang YX; Shen B
    Biochim Biophys Acta Mol Basis Dis; 2023 Jun; 1869(5):166704. PubMed ID: 37001703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of CXC chemokines and their receptors in cancer.
    Vandercappellen J; Van Damme J; Struyf S
    Cancer Lett; 2008 Aug; 267(2):226-44. PubMed ID: 18579287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct CXC chemokines mediate tumorigenicity of prostate cancer cells.
    Moore BB; Arenberg DA; Stoy K; Morgan T; Addison CL; Morris SB; Glass M; Wilke C; Xue YY; Sitterding S; Kunkel SL; Burdick MD; Strieter RM
    Am J Pathol; 1999 May; 154(5):1503-12. PubMed ID: 10329603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Effect of Hypoxia on the Expression of CXC Chemokines and CXC Chemokine Receptors-A Review of Literature.
    Korbecki J; Kojder K; Kapczuk P; Kupnicka P; Gawrońska-Szklarz B; Gutowska I; Chlubek D; Baranowska-Bosiacka I
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33467722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of ligand-receptor system between stromal-cell-derived factor-1 and CXC chemokine receptor 4 in human prostate cancer: a possible predictor of metastasis.
    Mochizuki H; Matsubara A; Teishima J; Mutaguchi K; Yasumoto H; Dahiya R; Usui T; Kamiya K
    Biochem Biophys Res Commun; 2004 Jul; 320(3):656-63. PubMed ID: 15240098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic Analysis of CXC Chemokine-Vascular Endothelial Growth Factor A Network in Colonic Adenocarcinoma from the Perspective of Angiogenesis.
    Situ Y; Lu X; Cui Y; Xu Q; Deng L; Lin H; Shao Z; Chen J
    Biomed Res Int; 2022; 2022():5137301. PubMed ID: 36246978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CXC family of chemokines as prognostic or predictive biomarkers and possible drug targets in colorectal cancer.
    Cabrero-de Las Heras S; Martínez-Balibrea E
    World J Gastroenterol; 2018 Nov; 24(42):4738-4749. PubMed ID: 30479461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The inflammatory cytokine tumor necrosis factor-alpha generates an autocrine tumor-promoting network in epithelial ovarian cancer cells.
    Kulbe H; Thompson R; Wilson JL; Robinson S; Hagemann T; Fatah R; Gould D; Ayhan A; Balkwill F
    Cancer Res; 2007 Jan; 67(2):585-92. PubMed ID: 17234767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemokine axes CXCL12/CXCR4 and CXCL16/CXCR6 correlate with lymph node metastasis in epithelial ovarian carcinoma.
    Guo L; Cui ZM; Zhang J; Huang Y
    Chin J Cancer; 2011 May; 30(5):336-43. PubMed ID: 21527066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulated CXCL14 is associated with poor survival outcomes and promotes ovarian cancer cells proliferation.
    Li X; Zhao L; Meng T
    Cell Biochem Funct; 2020 Jul; 38(5):613-620. PubMed ID: 32077118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The emerging role of CXC chemokines in epithelial ovarian cancer.
    Rainczuk A; Rao J; Gathercole J; Stephens AN
    Reproduction; 2012 Sep; 144(3):303-17. PubMed ID: 22771929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.